Oliver K Jawitz1, Vignesh Raman2, Yaron Barac2, Michael S Mulvihill2, Carrie Moore2, Ashley Y Choi2, Matthew Hartwig2, Jacob Klapper2. 1. Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina. Electronic address: oliver.jawitz@duke.edu. 2. Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Abstract
BACKGROUND: Donor brain death duration (BDD) may impact posttransplant graft function and survival in lung transplant. METHODS: We queried the 2007 to 2018 United Network for Organ Sharing Registry for adult recipients undergoing first-time isolated lung transplant. Cox proportional hazard modeling with splines enabled identification of 3 donor brain death intervals for subsequent analysis: short (<24 hours), reference (24-60 hours), and long (>60 hours). The primary outcome was posttransplant survival. RESULTS: In total, 19,721 donors and recipients met inclusion criteria. Median time from donor brain death until cross-clamp was 36.6 hours (interquartile range, 19.5). Unadjusted overall survival between cohorts was equivalent (log-rank P = .42); however, longer BDD was associated with improved bronchiolitis obliterans syndrome (BOS)-free survival (log-rank P < .001). On multivariable Cox proportional hazards regression, BDD was not associated with recipient survival (P > .05). Similarly, logistic regression did not identify an independent association between BDD and primary graft dysfunction (P > .05). Increased BDD was, however, associated with a decreased risk of acute rejection (long vs reference; adjusted odds ratio, 0.78; 95% confidence interval, 0.64-0.94) and improved BOS-free survival (long vs reference; adjusted hazard ratio, 0.88; 95% confidence interval, 0.81-0.96). CONCLUSIONS: Donor BDD is not associated with posttransplant survival or primary graft dysfunction. Long donor BDD, however, is associated with a decreased risk for acute rejection and improved BOS-free survival. Therefore, lung allografts from donors with a prolonged length of time from brain death until explant should not be viewed less favorably by donor selection centers.
BACKGROUND:Donorbrain death duration (BDD) may impact posttransplant graft function and survival in lung transplant. METHODS: We queried the 2007 to 2018 United Network for Organ Sharing Registry for adult recipients undergoing first-time isolated lung transplant. Cox proportional hazard modeling with splines enabled identification of 3 donorbrain death intervals for subsequent analysis: short (<24 hours), reference (24-60 hours), and long (>60 hours). The primary outcome was posttransplant survival. RESULTS: In total, 19,721 donors and recipients met inclusion criteria. Median time from donorbrain death until cross-clamp was 36.6 hours (interquartile range, 19.5). Unadjusted overall survival between cohorts was equivalent (log-rank P = .42); however, longer BDD was associated with improved bronchiolitis obliterans syndrome (BOS)-free survival (log-rank P < .001). On multivariable Cox proportional hazards regression, BDD was not associated with recipient survival (P > .05). Similarly, logistic regression did not identify an independent association between BDD and primary graft dysfunction (P > .05). Increased BDD was, however, associated with a decreased risk of acute rejection (long vs reference; adjusted odds ratio, 0.78; 95% confidence interval, 0.64-0.94) and improved BOS-free survival (long vs reference; adjusted hazard ratio, 0.88; 95% confidence interval, 0.81-0.96). CONCLUSIONS:DonorBDD is not associated with posttransplant survival or primary graft dysfunction. Long donorBDD, however, is associated with a decreased risk for acute rejection and improved BOS-free survival. Therefore, lung allografts from donors with a prolonged length of time from brain death until explant should not be viewed less favorably by donor selection centers.
Authors: Giuseppe Citerio; Marcelo Cypel; Geoff J Dobb; Beatriz Dominguez-Gil; Jennifer A Frontera; David M Greer; Alex R Manara; Sam D Shemie; Martin Smith; Franco Valenza; Eelco F M Wijdicks Journal: Intensive Care Med Date: 2016-01-11 Impact factor: 17.440
Authors: Shana Wauters; Geert M Verleden; Ann Belmans; Willy Coosemans; Paul De Leyn; Philippe Nafteux; Toni Lerut; Dirk Van Raemdonck Journal: Eur J Cardiothorac Surg Date: 2011-01-12 Impact factor: 4.191
Authors: Zhifei Sun; Mohamed A Adam; Jina Kim; Daniel P Nussbaum; Ehsan Benrashid; Christopher R Mantyh; John Migaly Journal: Dis Colon Rectum Date: 2016-02 Impact factor: 4.585
Authors: Bernard Cantin; Bernard W K Kwok; Michael C Y Chan; Hannah A Valantine; Philip E Oyer; Robert C Robbins; Sharon A Hunt Journal: Transplantation Date: 2003-11-15 Impact factor: 4.939
Authors: Verner Eerola; Ilkka Helanterä; Anna But; Marko Lempinen; Heikki Mäkisalo; Arno Nordin; Helena Isoniemi; Ville Sallinen Journal: Clin J Am Soc Nephrol Date: 2021-03-08 Impact factor: 8.237
Authors: Verner Eerola; Ilkka Helanterä; Fredrik Åberg; Marko Lempinen; Heikki Mäkisalo; Arno Nordin; Helena Isoniemi; Ville Sallinen Journal: Transpl Int Date: 2022-08-31 Impact factor: 3.842